QA: Mirati Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001576263_2023_Mirati_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001576263, Mirati Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,108,961,000
1 IntangibleAssetsNetIncludingGoodwill 14,914,000
2 PropertyPlantAndEquipmentNet 17,540,000
3 remainder_Assets 61,232,000
4 LiabilitiesCurrent 159,448,000
5 LiabilitiesNoncurrent 46,683,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 755,279,611
9 ResearchAndDevelopmentExpense 567,032,898
10 remainder_Expenses 1,694,721
11 remainder_Revenues 49,525,780
12 remainder_NetIncome -5,270,920
13 remainder_ComprehensiveNetIncome -73,036,806
  yvar yval
0 Assets 1,202,647,000
1 Liabilities 206,131,000
2 Expenses 1,324,007,230
3 Revenues 49,525,780
4 StockholdersEquity 996,516,000
5 NetIncome -1,279,752,370
6 ComprehensiveNetIncome -1,316,270,773
7 BaseVar 1,430,309,368
8 EconomicCapitalRatiobeforeLimitedLiability 1.22
9 EconomicCapitalRatio 2.47

Edgar->Model Mapping

Feature Distribution

Change over Time